Proteomics in early detection of cancer

被引:1
|
作者
Srinivas, PR
Srivastava, S
Hanash, S
Wright, GL
机构
[1] NCI, Div Canc Prevent, Canc Biomarkers Res Grp, Rockville, MD 20852 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA
[4] Eastern Virginia Med Sch, Virginia Prostate Canc, Norfolk, VA 23501 USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Early detection is critical in cancer control and prevention. Biomarkers help in this process by providing valuable information about a the status of a cell at any given point in time. As a cell transforms from nondiseased to neoplastic, distinct changes occur that could be potentially detected through the identification of the appropriate biomarkers. Biomarker research has benefited from advances in technology such as proteomics. We discuss here ongoing research in this field, focusing on proteomic technologies. The advances in two-dimensional electrophoresis and mass spectrometry are discussed in light of their contribution to biomarker research. Chip-based techniques, such as surface-enhanced laser desorption, and ionization and emerging methods, such as tissue and antibody arrays, are also discussed. The development of bioinformatic tools that have and are being developed in parallel to proteomics is also addressed. This report brings into focus the efforts of the Early Detection Research Network at the National Cancer Institute in harnessing scientific expertise from leading institutions to identify and validate biomarkers for early detection and risk assessment. (C) 2001 American Association for Clinical Chemistry.
引用
收藏
页码:1901 / 1911
页数:11
相关论文
共 50 条
  • [1] Application of Proteomics to Cancer Early Detection
    Hanash, Samir
    Taguchi, Ayumu
    [J]. CANCER JOURNAL, 2011, 17 (06): : 423 - 428
  • [2] Clinical Proteomics in the Early Detection of Breast Cancer
    Celis, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S34 - S35
  • [3] Quantitative Proteomics for the Early Detection of Colorectal Cancer
    Gould, Tiffany
    Jamaluddin, Muhammad F. B.
    Pockney, Peter
    Dun, Matthew
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 24 - 25
  • [4] Serniology, proteomics, and the early detection of symptomatic cancer
    Porta, M
    Fernandez, E
    Alguacil, J
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (09) : 815 - 819
  • [5] Serum proteomics for early detection of colorectal cancer
    Tollenaar, Rob
    [J]. CELLULAR ONCOLOGY, 2008, 30 (02) : 109 - 109
  • [6] The evolving role of proteomics in the early detection of breast cancer
    Pawlik, TM
    Kuerer, HM
    [J]. INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 2005, 50 (05) : 212 - 216
  • [7] Proteomics for early detection of colorectal cancer: recent updates
    Alnabulsi, Abdo
    Murray, Graeme I.
    [J]. EXPERT REVIEW OF PROTEOMICS, 2018, 15 (01) : 55 - 63
  • [8] Tissue and plasma proteomics for early stage cancer detection
    Peng, Liyuan
    Cantor, David I.
    Huang, Canhua
    Wang, Kui
    Baker, Mark S.
    Nice, Edouard C.
    [J]. MOLECULAR OMICS, 2018, 14 (06) : 405 - 423
  • [9] Proteomics as a Method for Early Detection of Cancer: A Review of Proteomics, Exhaled Breath Condensate, and Lung Cancer Screening
    Dean H. Conrad
    Jesse Goyette
    Paul S. Thomas
    [J]. Journal of General Internal Medicine, 2008, 23 : 78 - 84
  • [10] Proteomics as a method for early detection of cancer: A review of proteomics, exhaled breath condensate, and lung cancer screening
    Conrad, Dean H.
    Goyette, Jesse
    Thomas, Paul S.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (Suppl 1) : 78 - 84